These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 32733702)
41. Elevated blood pressure level based on 2017 ACC/AHA guideline in relation to stroke risk in rural areas of Liaoning province. Xie Y; Ma M; Li Z; Guo X; Sun G; Sun Z; Zheng J; Sun Y; Zheng L BMC Cardiovasc Disord; 2019 Nov; 19(1):258. PubMed ID: 31747878 [TBL] [Abstract][Full Text] [Related]
42. Increased Risk of Hypertension in Young Adults in Southwest China: Impact of the 2017 ACC/AHA High Blood Pressure Guideline. Li D; Zeng X; Huang Y; Lei H; Li G; Zhang N; Huang W Curr Hypertens Rep; 2019 Feb; 21(3):21. PubMed ID: 30820764 [TBL] [Abstract][Full Text] [Related]
43. Awareness, Treatment and Control of Pre-hypertension and Hypertension among Adults in Iran. Esteghamati A; Etemad K; Koohpayehzadeh J; Abbasi M; Meysamie A; Khajeh E; Asgari F; Noshad S; Rafei A; Mousavizadeh M; Neishaboury MR; Afarideh M; Nakhjavani M Arch Iran Med; 2016 Jul; 19(7):456-64. PubMed ID: 27362238 [TBL] [Abstract][Full Text] [Related]
44. Impact of 2017 ACC/AHA guideline on prevalence, awareness, treatment, control, and determinants of hypertension: a population-based cross-sectional study in southwest of Iran. Sadeghi F; Cheraghian B; Mohammadi Z; Sepanlou SG; Masoudi S; Rahimi Z; Danehchin L; Paridar Y; Abolnezhadian F; Noori M; Mard SA; Shayesteh AA; Poustchi H Popul Health Metr; 2021 May; 19(1):26. PubMed ID: 34034752 [TBL] [Abstract][Full Text] [Related]
45. Epidemiological features of hypertension among ischemic survivors in Northeast China: insights from a population-based study, 2017-2019. Jing L; Tian Y; Ren G; Zhang L; Shi L; Dai D; Xing L; Liu S BMC Public Health; 2021 Sep; 21(1):1648. PubMed ID: 34503467 [TBL] [Abstract][Full Text] [Related]
46. Gender-specific association between the blood pressure category according to the updated ACC/AHA guidelines for hypertension and cardio-ankle vascular index: a community-based cohort study. Kamon T; Kaneko H; Itoh H; Kiriyama H; Mizuno Y; Morita H; Yamamichi N; Komuro I J Cardiol; 2020 May; 75(5):578-582. PubMed ID: 31874723 [TBL] [Abstract][Full Text] [Related]
47. Insight into blood pressure targets for universal coverage of hypertension services in Iran: the 2017 ACC/AHA versus JNC 8 hypertension guidelines. Mahdavi M; Parsaeian M; Mohajer B; Modirian M; Ahmadi N; Yoosefi M; Mehdipour P; Djalalinia S; Rezaei N; Haghshenas R; Pazhuheian F; Madadi Z; Sabooni M; Razi F; Samiee SM; Farzadfar F BMC Public Health; 2020 Mar; 20(1):347. PubMed ID: 32183754 [TBL] [Abstract][Full Text] [Related]
48. Factors associated with awareness, treatment and control of hypertension among 3579 hypertensive adults in China: data from the China Health and Nutrition Survey. Wei J; Mi Y; Li Y; Xin B; Wang Y BMC Public Health; 2021 Mar; 21(1):423. PubMed ID: 33648483 [TBL] [Abstract][Full Text] [Related]
49. Prevalence of hypertension at high altitude: cross-sectional survey in Ladakh, Northern India 2007-2011. Norboo T; Stobdan T; Tsering N; Angchuk N; Tsering P; Ahmed I; Chorol T; Kumar Sharma V; Reddy P; Singh SB; Kimura Y; Sakamoto R; Fukutomi E; Ishikawa M; Suwa K; Kosaka Y; Nose M; Yamaguchi T; Tsukihara T; Matsubayashi K; Otsuka K; Okumiya K BMJ Open; 2015 Apr; 5(4):e007026. PubMed ID: 25897026 [TBL] [Abstract][Full Text] [Related]
50. Prevalence and treatment of hypertension in China: impacts of 2017 American College of Cardiology/American Heart Association High Blood Pressure Guideline. Yang C; Wang J; Gao B; Zhang Y; Wang F; Zhang L; Zhao M; Huo Y; Sci Bull (Beijing); 2018 Apr; 63(8):488-493. PubMed ID: 36658809 [TBL] [Abstract][Full Text] [Related]
51. Associations of blood pressure categories defined by 2017 ACC/AHA guidelines with mortality in China: Pooled results from three prospective cohorts. Liu N; Yang JJ; Meng R; Pan XF; Zhang X; He M; Li H; Gao YT; Xiang YB; Shu XO; Zheng W; Wu T; Yu D; Pan A Eur J Prev Cardiol; 2020 Mar; 27(4):345-354. PubMed ID: 31288541 [TBL] [Abstract][Full Text] [Related]
52. [Prevalence, awareness, treatment and control of hypertension in Chinese adults]. Gu DF; Jiang H; Wu XG; Reynolds K; Gan WQ; Liu DH; Su SY; Duan XF; Huang GY; Whelton PK Zhonghua Yu Fang Yi Xue Za Zhi; 2003 Mar; 37(2):84-9. PubMed ID: 12839656 [TBL] [Abstract][Full Text] [Related]
53. Prevalence, awareness, medication, control, and risk factors associated with hypertension in Yi ethnic group aged 50 years and over in rural China: the Yunnan minority eye study. Chen L; Zong Y; Wei T; Sheng X; Shen W; Li J; Niu Z; Zhou H; Zhang Y; Yuan Y; Chen Q; Zhong H BMC Public Health; 2015 Apr; 15():383. PubMed ID: 25886600 [TBL] [Abstract][Full Text] [Related]
54. Use of angiotensin II receptor blockers alone and in combination with other drugs: a large clinical experience trial. Weir MR; Wang RY J Renin Angiotensin Aldosterone Syst; 2001 Mar; 2(1_suppl):S217-S222. PubMed ID: 28095219 [TBL] [Abstract][Full Text] [Related]
55. Trends in Prevalence and Control of Hypertension According to the 2017 American College of Cardiology/American Heart Association (ACC/AHA) Guideline. Dorans KS; Mills KT; Liu Y; He J J Am Heart Assoc; 2018 Jun; 7(11):. PubMed ID: 29858369 [TBL] [Abstract][Full Text] [Related]
56. Association Between Blood Pressure Classification Using the 2017 ACC/AHA Blood Pressure Guideline and Retinal Atherosclerosis. Matsuoka S; Kaneko H; Yano Y; Itoh H; Fukui A; Morita K; Kiriyama H; Kamon T; Fujiu K; Seki H; Michihata N; Jo T; Takeda N; Morita H; Nakamura S; Yokoo T; Nishiyama A; Node K; Yasunaga H; Komuro I Am J Hypertens; 2021 Oct; 34(10):1049-1056. PubMed ID: 34008020 [TBL] [Abstract][Full Text] [Related]
57. Effectiveness and tolerability of fixed-dose combination enalapril plus nitrendipine in hypertensive patients: results of the 3-month observational, post-marketing, multicentre, prospective CENIT study. Sierra A; Roca-Cusachs A; Redón J; Marín R; Luque M; Figuera M; Garcia-Garcia M; Falkon L Clin Drug Investig; 2009; 29(7):459-469. PubMed ID: 19499963 [TBL] [Abstract][Full Text] [Related]
58. Prevalence, awareness, treatment and control of hypertension and salt intake in Portugal: changes over a decade. The PHYSA study. Polonia J; Martins L; Pinto F; Nazare J J Hypertens; 2014 Jun; 32(6):1211-21. PubMed ID: 24675681 [TBL] [Abstract][Full Text] [Related]
59. Impact of the 2017 ACC/AHA guidelines on the prevalence of hypertension among Indian adults: Results from a cross-sectional survey. Gupta K; Ramakrishnan S; Zachariah G; Rao JS; Mohanan PP; Venugopal K; Sateesh S; Sethi R; Jain D; Bardolei N; Mani K; Kakar TS; Jain V; Gupta P; Gupta R; Bansal S; Nath RK; Tyagi S; Wander GS; Gupta S; Mandal S; Senguttuvan NB; Subramanyam G; Roy D; Datta S; Ganguly K; Routray SN; Mishra SS; Singh BP; Bharti BB; Das MK; Deb PK; Deedwania P; Seth A; Int J Cardiol Hypertens; 2020 Dec; 7():100055. PubMed ID: 33465185 [TBL] [Abstract][Full Text] [Related]
60. Hypertension prevalence, awareness, treatment, and control in northeast China: a population-based cross-sectional survey. Zhang FL; Guo ZN; Xing YQ; Wu YH; Liu HY; Yang Y J Hum Hypertens; 2017 Dec; 32(1):54-65. PubMed ID: 29180804 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]